Efficacy of Continuous Apomorphine Infusion on Cognitive and Neuropsychological Functions in Parkinson's Disease

NCT01039090 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Parkinsons's Disease

Interventions

DRUG: Continuous Apomorphine infusion
DRUG: Usual dopaminergic per os treatment

Sponsor

Rennes University Hospital